Spectral-domain optical coherence tomography imaging findings in patients receiving teprotumumab for thyroid eye disease

Truong, T., Silkiss, R. Z., Amoroso, J. R., Li, H., Hoang, Q. V., Eliasieh, K., & Jung, J. J. (2025). Spectral-domain optical coherence tomography imaging findings in patients receiving teprotumumab for thyroid eye disease. American Journal of Ophthalmology Case Reports, 38, 102282. https://doi.org/10.1016/j.ajoc.2025.102282
Authors:
Timothy Truong
Rona Z. Silkiss
Johnell Renz Amoroso
Huanye Li
Quan V. Hoang
Kasra Eliasieh
Jesse J. Jung
Affiliated Authors:
Quan V. Hoang
Columbia Affiliation:
Author Keywords:
choroidal thickness
ganglion cell analysis
insulin-like growth factor receptor-1 inhibition
insulin-like growth factor-1
retinal nerve fiber layer
spectral-domain optical coherence tomography
teprotumumab
thyroid eye disease
elink
Publication Type:
Article
Unique ID:
10.1016/j.ajoc.2025.102282
DOI:
10.1016/j.ajoc.2025.102282
Journal:
American Journal of Ophthalmology Case Reports
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: